Search
for
Sort by
Research 391–420 of 1000+
- A case series of 20 women with hidradenitis suppurativa treated with spironolactone
- UPDATE ON IDIOPATHIC HIRSUTISM: DIAGNOSIS AND TREATMENT
- Risk profile of non-cicatricial alopecia in females
- Hepatotoxicity with low- and ultralow-dose flutamide: a surveillance study on 203 hyperandrogenic young females
- Postpartum Alopecia
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Clinical and Demographic Characteristics of Patients Diagnosed with Polycystic Ovary Syndrome: A Cross-Sectional Observational Study
- Period problems: disorders of menstruation in adolescents
- Venous thromboembolism and women's health
- The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms – a review
- Chemical pharmacotherapy options for managing adult acne
- Treatment of hyperandrogenism in polycystic ovary syndrome
- A Review on Drug Induced Alopecia
- Adverse Reactions to Oral Retinoids An Update
- Short‐Term, Low‐Dose Spironolactone for Treatment of Hyperandrogenic Symptoms of Polycystic Ovary Syndrome—A Systematic Review
- Update on Polycystic Ovary Syndrome
- [PRACTICAL EXPERIENCES WITH OVULATION INHIBITION].
- Management of adolescent polycystic ovary syndrome
- Faculty Opinions recommendation of Finasteride treatment of female pattern hair loss.
- [Drug-induced alopecia: review of the literature].
- Migraine and the menopause transition
- Female pattern hair loss: current treatment concepts.
- Hair diseases: a big problem on a small surface
- No. 350-Hirsutism: Evaluation and Treatment
- Polycystic Ovary Syndrome: Explaining the Gynecological Aspects and Treatment Options to Patients
- Hormonal Therapies for Acne: A Comprehensive Update for Dermatologists
- Noncontraceptive Use of Contraceptive Agents
- The combination of ethinylestradiol/cyproterone acetate is temporarily withdrawn from the market in France. Is the measure justified?
- A Clinical Approach to Severe Insulin Resistance
- A Randomized Cohort Study: Is It Worth the Time to Receive Antiandrogenic Pretreatment Before Ovulation Induction for Women With Polycystic Ovary Syndrome?